Big Pharma Problem for HIV/AIDS

An application by Haiti on behalf of itself and other poor countries — many of which are known for their high HIV/AIDS infection rates — to extend the deadline for manufacturing generic AIDS drugs has been rejected by the World Trade Organization.
allAfrica